In vivo bone architecture in pompe disease using high-resolution peripheral computed tomography

Area of Science:

• Biomedical Engineering
• Metabolic Disorders
• Musculoskeletal Health

Background:

• Pompe disease (lysosomal acid alpha-glucosidase deficiency) primarily causes muscle weakness in adolescents and adults.
• Bone weakness is an under-recognized complication, potentially increasing fracture risk due to reduced mineral content and altered bone architecture.
• Loss of muscle function and mobility are implicated in bone integrity compromise.

Purpose of the Study:

• To evaluate the utility of high-resolution peripheral quantitative computed tomography (HR-pQCT) in monitoring bone health over time in Pompe disease patients.
• To observe longitudinal changes in bone mineral density and architecture in Pompe disease.
• To assess the impact of various therapeutic interventions on bone health.

Main Methods:

• Longitudinal study over 4 years involving four Pompe disease patients.
• Utilized high-resolution peripheral quantitative computed tomography (HR-pQCT) for bone assessment.
• Observed patients with varying treatment statuses (rhGAA, anti-resorptive therapy) and mobility levels, including vibration therapy.

Main Results:

• HR-pQCT effectively tracked longitudinal trends in bone mineral density and architecture.
• Decreased mobility and loading forces correlated with compromised bone integrity.
• Increased loading forces, such as vibration therapy and weight-bearing, showed potential to reverse negative bone trends.

Conclusions:

• HR-pQCT is a valuable tool for monitoring bone health in Pompe disease patients.
• Reduced mobility significantly impacts bone integrity in Pompe disease.
• Therapeutic interventions aimed at increasing physical loading can improve bone health outcomes.